Stay updated on Betalutin & Rituximab in FL: Safety/Efficacy Clinical Trial
Sign up to get notified when there's something new on the Betalutin & Rituximab in FL: Safety/Efficacy Clinical Trial page.

Latest updates to the Betalutin & Rituximab in FL: Safety/Efficacy Clinical Trial page
- CheckyesterdayChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1, while the page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe 403 Forbidden page and the footer's Home link were removed, restoring access to the study details page. This change does not modify the core study content.SummaryDifference0.5%

- Check22 days agoChange DetectedThe page now displays a 403 Forbidden error, replacing the previously visible study record content. The error screen indicates the study page is inaccessible.SummaryDifference18%

- Check43 days agoChange DetectedRevision label updated to v3.6.6 (replacing v3.6.5). This indicates a minor system update that does not affect the study details or page content.SummaryDifference0.1%

- Check50 days agoChange DetectedA new entry '2017 ( U.S. NIH Grant/Contract )' was added to the study's list of identifiers, indicating an NIH funding reference associated with the study.SummaryDifference0.1%

- Check64 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing the previous Revision: v3.6.4, signaling a minor version update to the page.SummaryDifference0.1%

Stay in the know with updates to Betalutin & Rituximab in FL: Safety/Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Betalutin & Rituximab in FL: Safety/Efficacy Clinical Trial page.